NO995290L - Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode - Google Patents

Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode

Info

Publication number
NO995290L
NO995290L NO995290A NO995290A NO995290L NO 995290 L NO995290 L NO 995290L NO 995290 A NO995290 A NO 995290A NO 995290 A NO995290 A NO 995290A NO 995290 L NO995290 L NO 995290L
Authority
NO
Norway
Prior art keywords
subdiafragmatic
immunization method
helicobacter
vaccine composition
parenteral immunization
Prior art date
Application number
NO995290A
Other languages
English (en)
Other versions
NO995290D0 (no
Inventor
Bruno Guy
Jean Haensler
Cynthia K Lee
Richard A Weltzin
Thomas P Monath
Original Assignee
Merieux Oravax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9705609A external-priority patent/FR2762788B1/fr
Application filed by Merieux Oravax filed Critical Merieux Oravax
Publication of NO995290D0 publication Critical patent/NO995290D0/no
Publication of NO995290L publication Critical patent/NO995290L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det beskrives anvendelse av et immunogent agens avledet fra Helicobacter, ved fremstillingen av en farmasøytisk blanding beregnet for induksjon av en T- hjelper 1 (Th1) type immunrespons mot Helicobacter, for å forhindre eller behandle en He//co6acter-infeksjon i et pattedyr. Dette oppnås særlig når den farmasøytiske blanding er ment administrert via den systemiske eller parenterale rute, for eksempel i den del av pattedyret som befinner seg under dets diafragma. Det beskrives dessuten en mukosal/parenteral immuniseringsmetode for forhindring eller behandling av Hefcobacter-infeksjon.
NO995290A 1997-04-30 1999-10-29 Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode NO995290L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9705609A FR2762788B1 (fr) 1997-04-30 1997-04-30 Composition vaccinale anti-helicobacter pour usage par voie systemique sous-diaphragmatique
FR9715731 1997-12-08
PCT/US1998/008890 WO1998048835A1 (en) 1997-04-30 1998-04-30 Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method

Publications (2)

Publication Number Publication Date
NO995290D0 NO995290D0 (no) 1999-10-29
NO995290L true NO995290L (no) 1999-12-29

Family

ID=26233514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995290A NO995290L (no) 1997-04-30 1999-10-29 Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode

Country Status (10)

Country Link
EP (1) EP1017417A1 (no)
JP (1) JP2002512619A (no)
KR (1) KR20010020366A (no)
CN (1) CN1254292A (no)
AU (1) AU751433B2 (no)
BR (1) BR9809426A (no)
CA (1) CA2289253A1 (no)
HU (1) HUP0003388A3 (no)
NO (1) NO995290L (no)
WO (1) WO1998048835A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029919D0 (en) * 2000-12-07 2001-01-24 Chiron Spa Helicobacter pylori prime & boost vaccination
ES2569907T3 (es) 2008-06-27 2016-05-13 Zoetis Services Llc Composiciones adyuvantes novedosas
UA130246C2 (uk) 2013-09-19 2025-12-31 Зоетіс Сервісіз Ллс Ад'ювант на основі олії
CN115317600A (zh) 2015-01-16 2022-11-11 硕腾服务有限责任公司 口蹄疫疫苗
CN108743929B (zh) * 2018-06-14 2021-07-27 四川大学 一种用作尿素清除剂的脲酶凝胶微球的制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333110T2 (de) * 1992-03-02 2004-05-06 Chiron S.P.A. Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
SK165197A3 (en) * 1995-06-07 1999-01-11 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics

Also Published As

Publication number Publication date
CA2289253A1 (en) 1998-11-05
KR20010020366A (ko) 2001-03-15
HUP0003388A3 (en) 2001-06-28
HUP0003388A2 (hu) 2001-02-28
CN1254292A (zh) 2000-05-24
EP1017417A1 (en) 2000-07-12
WO1998048835A1 (en) 1998-11-05
JP2002512619A (ja) 2002-04-23
AU7276898A (en) 1998-11-24
NO995290D0 (no) 1999-10-29
AU751433B2 (en) 2002-08-15
BR9809426A (pt) 2000-06-13

Similar Documents

Publication Publication Date Title
EP0705109A4 (en) ADJUVANTIES FOR VACCINE AGAINST THE RESPIRATORY SYNCITIAL VIRUS
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
KR970703164A (ko) 헬리코박터류 감염의 치료 및 예방용 항원 제제(treatment and prevention of helicobacter infection)
AU4951196A (en) Vaccines for plague
ZA932491B (en) Vaccines
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
NZ337885A (en) vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid
EP0330359A3 (en) Composition useful in the diagnosis and treating of hiv-1 infection
BR9814487A (pt) "vacina"
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
EP0672116A4 (en) DELETION MUTANTS AS A VACCINE AGAINST CHOLERA.
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
NO983474L (no) Ekspresjon av gruppe B Neisseria meningitidis ytre membran (MB3) protein fra gjµr og vaksiner
KR960700746A (ko) 헬리코박터 피롤리 관련 위십이지장 질환의 치료 방법(treatment of h. pylori associated gastroduodenal disease)
EP0804489A4 (no)
NO995290L (no) Anti-helicobacter-vaksineblanding for anvendelse av den subdiafragmatiske systemiske ruten og kombinert mukosal/parenteral immuniseringsmetode
WO2003083083A3 (en) Methods of using flt3-ligand in immunization protocols
GR3031491T3 (en) Mucosal administration of pneumococcal antigens.
CA2330313A1 (en) Immunization against and treatment for infection by h.pylori
GR3018820T3 (en) Use of il-4 to enhance immune response to immunogens in vaccines.
CA2457804A1 (en) Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
NO890565D0 (no) Forhindring og behandling av retroviral sykdom.
CA2394843A1 (en) A vaccine comprising lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application